Switch to Dark

Pricing

Learn

BSX - Boston Scientific Corp

119

$71.28

$0.08 (0.112%)

At market close

$71.22

-$0.06 (-0.090%)

After Hours 3/18/26, 9:31 PM

Score

4.04/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Income Statement Summary

Metrics

KPIs

View as %

Boston Scientific Corp

Stock Unlock

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Total Revenue	18.11%	13.36%	$5.02B	$5.06B	$4.66B 2025-03-31	$5.29B 2025-12-31	$5.29B 2025-12-31

Operating Expenses	22.36%	16.42%	$2.46B	$2.48B	$2.27B 2025-03-31	$2.64B 2025-12-31	$2.64B 2025-12-31

Net Interest Income Expense	--	-9.76%	-$90.25M	-$90.00M	-$99.00M 2025-09-30	-$82.00M 2025-03-31	-$90.00M 2025-12-31

Income Tax Expense	-86.14%	-77.44%	$123.00M	$139.50M	$30.00M 2025-12-31	$183.00M 2025-09-30	$30.00M 2025-12-31

Cost of Goods Sold (COGS)	13.63%	10.1%	$1.56B	$1.56B	$1.46B 2025-03-31	$1.64B 2025-06-30	$1.60B 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

#'s in thousands USD	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Total Revenue	5,286,000	5,065,000	5,061,000	4,663,000	42,069,000	8760718	5449791	7984392	4842823	9772274	3892560	3047687	5347260	3255672	5894582	5391897	269733	9834255
Cost of Goods Sold (COGS)	1,602,000	1,524,000	1,641,000	1,455,000	42,069,000	8931180	1757762	3306605	6332969	3554301	4096876	2378189	9167641	231816	7532585	4990801	1832170	8491868
Gross Profit	3,684,000	3,541,000	3,420,000	3,208,000	42,069,000	7255990	4661448	5033307	9478419	8531352	9797467	6991448	1625835	2299608	802857	362381	7417743	2368509
Operating Expenses	2,637,000	2,490,000	2,462,000	2,265,000	42,069,000	8660178	8096918	1580316	333446	8761463	4952782	1774141	2762978	3762994	2234354	385728	1029017	9808201
Research & Development	569,000	514,000	526,000	443,000	42,069,000	7237169	4832628	4372278	7311784	2584454	3941561	9305841	4690287	1639947	6736756	7345707	9693939	8546329
Selling, General & Administrative Expenses	1,834,000	1,741,000	1,716,000	1,597,000	42,069,000	4519505	2719739	4692039	383943	1457229	7599660	6153552	7483751	7334732	1826037	2814894	7511681	5116671
Operating Income or Loss	1,047,000	1,051,000	958,000	943,000	42,069,000	6220787	5265183	9138529	4762698	4755897	3579438	8672570	4880236	3205588	8882919	2787738	8372641	1280262
Interest Expense	-90,000	-87,000	-90,000	-82,000	42,069,000	7369229	1971961	4657331	3744104	1938054	3248758	1204871	3466247	5792882	3174142	8551429	8430084	7398282
Net Interest Income Expense	-90,000	-99,000	-90,000	-82,000	42,069,000	7173326	7099524	3758741	4982343	1699646	7859004	5799128	8467445	9527122	4523737	16074	9879718	1895170
Non-Recurring Items	-222,000	-3,000	-139,000	-22,000	42,069,000	5073184	1958582	8603813	7317354	5207785	1991718	2846281	2818931	8519696	6542882	9247084	508563	3938460
Total Other Income/Expense Net	-35,000	-10,000	212,000	-34,000	42,069,000	8967929	1682203	4946299	6547431	6572148	358593	198843	2458091	1696181	4899445	2921810	3733092	9919033
Income Before Tax	700,000	939,000	941,000	805,000	42,069,000	3938274	5041857	3420086	9238241	9084029	9695438	1261641	5885829	4264199	7643097	8553973	2535727	4817089
Income Tax Expense	30,000	183,000	146,000	133,000	42,069,000	6429303	65108	3110702	2559349	1362402	2245713	8831704	3082501	7045748	7953877	7902490	9787814	9653024
Earnings	672,000	755,000	797,000	674,000	42,069,000	6381239	2797119	3406622	2708515	9194788	7749669	7235937	6683625	4522761	999936	8211816	9704912	1279037
Adjusted Net Income	450,000	752,000	658,000	652,000	42,069,000	1077610	7216629	7585271	235938	55112	1801562	865586	140842	1025202	12857	8532273	6948785	9212268
Net Income After Taxes	670,000	756,000	795,000	672,000	42,069,000	407114	3384933	4470059	4704640	6007588	1718436	9981999	8738284	2027498	9136653	979332	8339526	5576249
Diluted Shares Outstanding	1,496,000	1,495,500	1,493,500	1,493,100	42,069	7894653	1648497	9812766	7035145	1186655	5166272	998817	6591145	8520482	4317591	6733019	4142014	5815411
Diluted EPS	0.45	0.5	0.53	0.45	42,069	2818459	6039334	2186790	9751055	2344318	1195280	1435486	8563253	329465	4755313	2020298	51392	9081043
Adjusted EPS	0.3	0.5	0.44	0.44	42,069	2636312	6702042	6575061	2837519	1133953	5018888	8886411	9967436	2885909	9588481	7335753	4170960	4726276
EBITDA	1,412,000	1,393,000	1,294,000	1,268,000	42,069,000	3864207	2245630	6456580	8261290	8342589	4223789	4805295	1607398	6167719	6283483	3473055	5479404	8952403